Researchers from the Second Affiliated Hospital of Nanjing Medical University, et al. have published a case report entitled "Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with ...
Results showed 80% of pediatric patients achieved clinical remission. The Food and Drug Administration (FDA) has expanded the approval of Cablivi ® (caplacizumab-yhdp) to include treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results